Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AJOVY in interictal migraine burden
NCT04461795Phase 4Completed
- Sponsor
- David True
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of fremanezumab in migraine, sponsored by David True. Started Dec 2020; status: completed.
02
Drugs
fremanezumab
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04461795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04461795.